Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Igm Biosciences Inc (IGMS)

Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Igm Biosciences Inc 325 EAST MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 USA

igmbio.com Employees: 149 P: 650-965-7873

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences Inc. is based in Mountain View, California.

Key Statistics

Overview:

Market Capitalization, $K 76,572
Enterprise Value, $K 49,912
Shares Outstanding, K 60,293
Annual Sales, $ 2,680 K
Annual Net Income, $ -195,800 K
Last Quarter Sales, $ 143,620 K
Last Quarter Net Income, $ 97,580 K
EBIT, $ -61,890 K
EBITDA, $ -59,660 K
60-Month Beta 0.60
% of Insider Shareholders 57.00%
% of Institutional Shareholders 42.79%
Float, K 25,926
% Float 43.00%
Short Volume Ratio 0.18

Growth:

1-Year Return -85.70%
3-Year Return -94.21%
5-Year Return -97.33%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 32.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.58 on 07/31/25
Next Earnings Date 08/13/25
Earnings Per Share ttm -0.90
EPS Growth vs. Prev Qtr 283.72%
EPS Growth vs. Prev Year 300.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IGMS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.35%
Return-on-Assets % -24.15%
Profit Margin % -7,305.97%
Debt/Equity 0.00
Price/Sales 29.26
Price/Cash Flow N/A
Price/Book 0.76
Book Value/Share 1.67
Interest Coverage -2.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar